carnitine has been researched along with Metastase in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To establish the safety, pharmacokinetic parameters, maximum-tolerated dose, and recommended dose of aplidine, a novel marine cyclodepsipeptide, in patients with advanced cancer." | 2.71 | Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies. ( Ady-Vago, N; Armand, JP; Chièze, S; Delbaldo, C; Faivre, S; Guzman, C; Jimeno, J; Lopez-Lazaro, L; Lozahic, S; Martin, JA; Pico, F; Raymond, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faivre, S | 1 |
| Chièze, S | 1 |
| Delbaldo, C | 1 |
| Ady-Vago, N | 1 |
| Guzman, C | 1 |
| Lopez-Lazaro, L | 1 |
| Lozahic, S | 1 |
| Jimeno, J | 1 |
| Pico, F | 1 |
| Armand, JP | 1 |
| Martin, JA | 1 |
| Raymond, E | 1 |
1 trial available for carnitine and Metastase
| Article | Year |
|---|---|
Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carnitine; Depsipeptides; Dose-Response Relationship | 2005 |